{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:48:11Z","timestamp":1790344091757,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s41030-025-00308-z","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T15:54:20Z","timestamp":1753458860000},"page":"535-551","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Practical Approach to Pleural Infection"],"prefix":"10.1007","volume":"11","author":[{"given":"Steven J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5071-0324","authenticated-orcid":false,"given":"Benjamin J.","family":"Pippard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"issue":"Suppl","key":"308_CR1","first-page":"ii41","volume":"65","author":"HE Davies","year":"2010","unstructured":"Davies HE, Davies RJ, Davies CW. Management of pleural infection in adults: British thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl):ii41-53.","journal-title":"Thorax"},{"key":"308_CR2","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.athoracsur.2007.11.031","volume":"85","author":"H Christopoulou-Aletra","year":"2008","unstructured":"Christopoulou-Aletra H, Papavramidou N. \u2018Empyemas\u2019 of the thoracic cavity in the Hippocratic Corpus. Ann Thorac Surg. 2008;85:1132\u20134.","journal-title":"Ann Thorac Surg"},{"key":"308_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/0003-4975(89)90100-8","volume":"48","author":"RM Peters","year":"1989","unstructured":"Peters RM. Empyema thoracis: historical perspective. Ann Thorac Surg. 1989;48:306\u20138.","journal-title":"Ann Thorac Surg"},{"key":"308_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thorax-2022-219784","volume":"78","author":"ME Roberts","year":"2023","unstructured":"Roberts ME, Rahman NM, Maskell NA, et al. British thoracic society guideline for pleural disease. Thorax. 2023;78:1\u201342.","journal-title":"Thorax"},{"key":"308_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s41030-020-00140-7","volume":"7","author":"A Sundaralingam","year":"2021","unstructured":"Sundaralingam A, Banka R, Rahman NM. Management of pleural infection. Pulm Ther. 2021;7:59\u201374.","journal-title":"Pulm Ther"},{"key":"308_CR6","first-page":"186","volume":"4","author":"A Rosenstengel","year":"2012","unstructured":"Rosenstengel A. Pleural infection\u2014current diagnosis and management. J Thorac Dis. 2012;4:186\u201393.","journal-title":"J Thorac Dis"},{"key":"308_CR7","first-page":"992","volume":"7","author":"L McCauley","year":"2015","unstructured":"McCauley L, Dean N. Pneumonia and empyema: causal, casual or unknown. J Thorac Dis. 2015;7:992\u20138.","journal-title":"J Thorac Dis"},{"key":"308_CR8","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0146-2023","volume":"19","author":"A Elsheikh","year":"2023","unstructured":"Elsheikh A, Bhatnagar M, Rahman N. Diagnosis and management of pleural infection. Breathe. 2023;19: 230146.","journal-title":"Breathe"},{"key":"308_CR9","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1086\/522996","volume":"45","author":"SA Sahn","year":"2007","unstructured":"Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis. 2007;45:1480\u20136.","journal-title":"Clin Infect Dis"},{"key":"308_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/thx.2008.105080","volume":"64","author":"JD Chalmers","year":"2009","unstructured":"Chalmers JD, Singanayagam A, Murray MP, Scally C, Fawzi A, Hill AT. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009;64:592\u20137.","journal-title":"Thorax"},{"key":"308_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1513\/pats.200510-113JH","volume":"3","author":"RW Light","year":"2006","unstructured":"Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3:75\u201380.","journal-title":"Proc Am Thorac Soc"},{"key":"308_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/resp.13395","volume":"24","author":"F Brims","year":"2019","unstructured":"Brims F, Popowicz N, Rosenstengel A, et al. Bacteriology and clinical outcomes of patients with culture-positive pleural infection in Western Australia: a 6-year analysis. Respirology. 2019;24:171\u20138.","journal-title":"Respirology"},{"key":"308_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.crad.2020.12.017","volume":"76","author":"J Franklin","year":"2021","unstructured":"Franklin J, Talwar A, Addala D, et al. CT appearances of pleural infection: analysis of the second Multi-centre Intra-pleural Sepsis Trial (MIST 2) cohort. Clin Radiol. 2021;76:436\u201342.","journal-title":"Clin Radiol"},{"key":"308_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s41030-022-00195-8","volume":"8","author":"B Pippard","year":"2022","unstructured":"Pippard B, Bhatnagar M, McNeill L, Donnelly M, Frew K, Aujayeb A. Hepatic hydrothorax: a narrative review. Pulm Ther. 2022;8:241\u201354.","journal-title":"Pulm Ther"},{"key":"308_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0003-4975(91)90443-T","volume":"51","author":"JA Smith","year":"1991","unstructured":"Smith JA, Mullerworth MH, Westlake GW, Tatoulis J. Empyema thoracis: 14-year experience in a teaching center. Ann Thorac Surg. 1991;51:39\u201342.","journal-title":"Ann Thorac Surg"},{"key":"308_CR16","first-page":"85","volume":"15","author":"C Finley","year":"2008","unstructured":"Finley C, Clifton J, Fitzgerald JM, Yee J. Empyema: an increasing concern in Canada. Can Respir J. 2008;15:85\u20139.","journal-title":"Can Respir J"},{"issue":"1","key":"308_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1378\/chest.13-1912","volume":"145","author":"M S\u00f8gaard","year":"2014","unstructured":"S\u00f8gaard M, Nielsen RB, N\u00f8rgaard M, Kornum JB, Sch\u00f8nheyder HC, Thomsen RW. Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema: a 15-year Danish nationwide cohort study. Chest. 2014;145(1):189\u201392.","journal-title":"Chest"},{"key":"308_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1136\/thx.2010.156406","volume":"66","author":"CG Grijalva","year":"2011","unstructured":"Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax. 2011;66:663\u20138.","journal-title":"Thorax"},{"key":"308_CR19","doi-asserted-by":"publisher","first-page":"2003546","DOI":"10.1183\/13993003.03546-2020","volume":"57","author":"DT Arnold","year":"2020","unstructured":"Arnold DT, Hamilton FW, Morris TT, et al. Epidemiology of pleural empyema in English hospitals and the impact of influenza. Eur Respir J. 2020;57:2003546.","journal-title":"Eur Respir J"},{"key":"308_CR20","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.chest.2015.12.027","volume":"149","author":"NC Dean","year":"2016","unstructured":"Dean NC, Griffith PP, Sorensen JS, Mcauley L, Jones BE, Lee YCG. Pleural effusions at first ED encounter predict worse clinical outcomes in patients with pneumonia. Chest. 2016;149:1509\u201315.","journal-title":"Chest"},{"key":"308_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/17476348.2019.1578212","volume":"13","author":"EO Bedawi","year":"2019","unstructured":"Bedawi EO, Hassan M, McCracken D, Rahman NM. Pleural infection: a closer look at the etiopathogenesis, microbiology and role of antibiotics. Expert Rev Respir Med. 2019;13:337\u201347.","journal-title":"Expert Rev Respir Med"},{"key":"308_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S2213-2600(15)00185-X","volume":"3","author":"JP Corcoran","year":"2015","unstructured":"Corcoran JP, Wrightson JM, Belcher E, DeCamp MM, Feller-Kopman D, Rahman NM. Pleural infection: past, present, and future directions. Lancet Respir Med. 2015;3:563\u201377.","journal-title":"Lancet Respir Med"},{"key":"308_CR23","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1378\/chest.15-1130","volume":"148","author":"JM Wrightson","year":"2015","unstructured":"Wrightson JM, Wray JA, Street TL, et al. Absence of atypical pathogens in pleural infection. Chest. 2015;148:e102\u20133.","journal-title":"Chest"},{"key":"308_CR24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1164\/rccm.200601-074OC","volume":"174","author":"NA Maskell","year":"2006","unstructured":"Maskell NA, Batt S, Hedley EL, Davies CWH, Gillespie SH, Davies RJO. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174:817\u201323.","journal-title":"Am J Respir Crit Care Med"},{"key":"308_CR25","doi-asserted-by":"publisher","first-page":"1900542","DOI":"10.1183\/13993003.00542-2019","volume":"54","author":"M Hassan","year":"2019","unstructured":"Hassan M, Cargill T, Harriss E, et al. The microbiology of pleural infection in adults: a systematic review. Eur Respir J. 2019;54:1900542.","journal-title":"Eur Respir J"},{"key":"308_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cmi.2018.11.030","volume":"25","author":"R Dyrhovden","year":"2019","unstructured":"Dyrhovden R, Nygaard RM, Patel R, Ulvestad E, Kommedal \u00d8. The bacterial aetiology of pleural empyema. A descriptive and comparative metagenomic study. Clin Microbiol Infect. 2019;25:981\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"308_CR27","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1016\/S2666-5247(21)00327-X","volume":"3","author":"NI Kanellakis","year":"2022","unstructured":"Kanellakis NI, Wrightson JM, Gerry S, et al. The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing. Lancet Microbe. 2022;3:e294\u2013302.","journal-title":"Lancet Microbe"},{"key":"308_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1056\/NEJMoa042473","volume":"352","author":"NA Maskell","year":"2005","unstructured":"Maskell NA, Davies CWH, Nunn AJ, et al. U.K. Controlled trial of intrapleural Streptokinase for pleural infection. New Engl J Med. 2005;352:865\u201374.","journal-title":"New Engl J Med"},{"key":"308_CR29","doi-asserted-by":"publisher","first-page":"2000130","DOI":"10.1183\/13993003.00130-2020","volume":"56","author":"JP Corcoran","year":"2020","unstructured":"Corcoran JP, Psallidas I, Gerry S, et al. Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study. Eur Respir J. 2020;56:2000130.","journal-title":"Eur Respir J"},{"key":"308_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12931-025-03129-5","volume":"26","author":"C Wong","year":"2025","unstructured":"Wong C, Fan HC, Rahman NM, et al. Prognostic significance of pleural fluid microbiological positivity in pleural infection: a bicentric 10-year retrospective observational study. Respir Res. 2025;26:53.","journal-title":"Respir Res"},{"key":"308_CR31","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.2147\/IDR.S365757","volume":"15","author":"H Xu","year":"2022","unstructured":"Xu H, Hu X, Wang W, et al. Clinical application and evaluation of metagenomic next-generation sequencing in pulmonary infection with pleural effusion. Infect Drug Resist. 2022;15:2813\u201324.","journal-title":"Infect Drug Resist"},{"key":"308_CR32","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v4i1.650","volume":"4","author":"I Yovi","year":"2024","unstructured":"Yovi I, Syah NA, Anggraini D, Simanjuntak AM, Hanifah ZN, Elliyanti A. A comparative analysis between next-generation sequencing and conventional culture method to detect empyema-associated microorganisms: a systematic review. Narra J. 2024;4: e650.","journal-title":"Narra J"},{"key":"308_CR33","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0143-2023","volume":"19","author":"E McNally","year":"2023","unstructured":"McNally E, Ross C, Gleeson LE. The tuberculous pleural effusion. Breathe. 2023;19: 230143.","journal-title":"Breathe"},{"key":"308_CR34","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1378\/chest.117.6.1672","volume":"11","author":"SC Ko","year":"2000","unstructured":"Ko SC, Chen KY, Hsueh PR, Luh KT, Yang PC. Fungal empyema thoracis. Chest. 2000;11:1672\u20138.","journal-title":"Chest"},{"key":"308_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1183\/09031936.03.00051603","volume":"21","author":"D Jim\u00e9nez Castro","year":"2003","unstructured":"Jim\u00e9nez Castro D, D\u00edaz Nuevo G, P\u00e9rez-Rodr\u00edguez E, Light RW. Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions. Eur Respir J. 2003;21:220\u20134.","journal-title":"Eur Respir J"},{"key":"308_CR36","first-page":"204993612312238","volume":"11","author":"N Iqbal","year":"2023","unstructured":"Iqbal N, Ali AS, Zahid A, Jabeen K, Irfan M. Fungal empyema thoracis, a rare but an emerging entity: a retrospective case series from Pakistan. Ther Adv Infect Dis. 2023;11:20499361231223890.","journal-title":"Ther Adv Infect Dis"},{"key":"308_CR37","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3390\/jcm14051685","volume":"14","author":"C Pearce","year":"2025","unstructured":"Pearce C, Crapnell A, Bedawi EO, Rahman NM, Corcoran JP. Pleural infection: diagnosis, management and future directions. J Clin Med. 2025;14:1685.","journal-title":"J Clin Med"},{"key":"308_CR38","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1183\/09031936.00000211","volume":"38","author":"M Falguera","year":"2011","unstructured":"Falguera M, Carratal\u00e0 J, Bielsa S, et al. Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J. 2011;38:1173\u20139.","journal-title":"Eur Respir J"},{"key":"308_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijid.2013.12.013","volume":"25","author":"I Grau","year":"2014","unstructured":"Grau I, Ardanuy C, Calatayud L, Schulze MH, Li\u00f1ares J, Pallares R. Smoking and alcohol abuse are the most preventable risk factors for invasive pneumonia and other pneumococcal infections. Int J Infect Dis. 2014;25:59\u201364.","journal-title":"Int J Infect Dis"},{"key":"308_CR40","doi-asserted-by":"publisher","first-page":"1900541","DOI":"10.1183\/13993003.00541-2019","volume":"54","author":"TN Cargill","year":"2019","unstructured":"Cargill TN, Hassan M, Corcoran JP, et al. A systematic review of comorbidities and outcomes of adult patients with pleural infection. Eur Respir J. 2019;54:1900541.","journal-title":"Eur Respir J"},{"key":"308_CR41","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.jtcvs.2017.01.030","volume":"153","author":"KR Shen","year":"2017","unstructured":"Shen KR, Bribriesco A, Crabtree T, et al. The American association for thoracic surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153:e129\u201346.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"308_CR42","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1440-1843.2011.02006.x","volume":"16","author":"AG Brixey","year":"2011","unstructured":"Brixey AG, Yifeng L, Skouras V, Awadankiewicz A, Light RW. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology. 2011;16:1000\u20134.","journal-title":"Respirology"},{"key":"308_CR43","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.ajem.2016.09.021","volume":"34","author":"BK Moffett","year":"2016","unstructured":"Moffett BK, Panchabhai TS, Nakamatsu R, et al. Comparing posteroanterior with lateral and anteroposterior chest radiography in the initial detection of parapneumonic effusions. Am J Emerg Med. 2016;34:2402\u20137.","journal-title":"Am J Emerg Med"},{"key":"308_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130141","volume":"10","author":"N Tsujimoto","year":"2015","unstructured":"Tsujimoto N, Saraya T, Light RW, et al. A simple method for differentiating complicated parapneumonic effusion\/empyema from parapneumonic effusion using the split pleura sign and the amount of pleural effusion on thoracic CT. PLoS ONE. 2015;10: e0130141.","journal-title":"PLoS ONE"},{"key":"308_CR45","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/resp.13040","volume":"22","author":"JM Porcel","year":"2017","unstructured":"Porcel JM, Pardina M, Alem\u00e1n C, Pallisa E, Light RW, Bielsa S. Computed tomography scoring system for discriminating between parapneumonic effusions eventually drained and those cured only with antibiotics. Respirology. 2017;22:1199\u2013204.","journal-title":"Respirology"},{"key":"308_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13089-023-00356-z","volume":"16","author":"HA Zaki","year":"2024","unstructured":"Zaki HA, Albaroudi B, Shaban EE, et al. Advancement in pleura effusion diagnosis: a systematic review and meta-analysis of point-of-care ultrasound versus radiographic thoracic imaging. Ultrasound J. 2024;16:3.","journal-title":"Ultrasound J"},{"key":"308_CR47","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1111\/crj.12907","volume":"12","author":"G Marchetti","year":"2018","unstructured":"Marchetti G, Arondi S, Baglivo F, et al. New insights in the use of pleural ultrasonography for diagnosis and treatment of pleural disease. Clin Respir J. 2018;12:1993\u20132005.","journal-title":"Clin Respir J"},{"key":"308_CR48","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1164\/rccm.202206-1084OC","volume":"207","author":"EO Bedawi","year":"2023","unstructured":"Bedawi EO, Kanellakis NI, Corcoran JP, et al. The biological role of pleural fluid PAI-1 and sonographic septations in pleural infection: analysis of a prospectively collected clinical outcome study. Am J Respir Crit Care Med. 2023;207:731\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"308_CR49","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1164\/rccm.200801-062OC","volume":"178","author":"NM Rahman","year":"2008","unstructured":"Rahman NM, Mishra EK, Davies HE, Davies RJ, Lee YC. Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. Am J Respir Crit Care Med. 2008;178:483\u201390.","journal-title":"Am J Respir Crit Care Med"},{"key":"308_CR50","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1378\/chest.126.6.2022","volume":"126","author":"NA Maskell","year":"2004","unstructured":"Maskell NA, Gleeson FV, Darby M, Davies RJO. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions. Chest. 2004;126:2022\u20134.","journal-title":"Chest"},{"key":"308_CR51","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chest.2018.02.031","volume":"154","author":"I Psallidas","year":"2018","unstructured":"Psallidas I, Kanellakis NI, Bhatnagar R, et al. A pilot feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (the AUDIO study). Chest. 2018;154:766\u201372.","journal-title":"Chest"},{"key":"308_CR52","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/thx.2010.157842","volume":"66","author":"SM Menzies","year":"2011","unstructured":"Menzies SM, Rahman NM, Wrightson JM, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax. 2011;66:658\u201362.","journal-title":"Thorax"},{"key":"308_CR53","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1164\/rccm.201911-2169OC","volume":"20","author":"DT Arnold","year":"2020","unstructured":"Arnold DT, Hamilton FW, Elvers KT, et al. Pleural Fluid suPAR levels predict the need for invasive management in parapneumonic effusions. Am J Respir Crit Care Med. 2020;20:1545\u201353.","journal-title":"Am J Respir Crit Care Med"},{"key":"308_CR54","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2014.02.005","volume":"68","author":"OGM Bakker","year":"2014","unstructured":"Bakker OGM, Hemmes SNT, Backes Y, et al. SuPAR in pleural fluid may function as a biological marker for infection in critically ill patients with pleural effusions. J Infect. 2014;68:607\u20139.","journal-title":"J Infect"},{"key":"308_CR55","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.21037\/jtd-23-1636","volume":"16","author":"M Bhatnagar","year":"2024","unstructured":"Bhatnagar M, Fisher A, Ramsaroop S, Carter A, Pippard B. Chylothorax: pathophysiology, diagnosis, and management\u2013a comprehensive review. J Thorac Dis. 2024;16:1645\u201361.","journal-title":"J Thorac Dis"},{"key":"308_CR56","doi-asserted-by":"publisher","first-page":"2201062","DOI":"10.1183\/13993003.01062-2022","volume":"61","author":"EO Bedawi","year":"2023","unstructured":"Bedawi EO, Ricciardi S, Hassan M, et al. ERS\/ESTS statement on the management of pleural infection in adults. Eur Respir J. 2023;61:2201062.","journal-title":"Eur Respir J"},{"key":"308_CR57","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/thorax-2023-220402","volume":"79","author":"DT Arnold","year":"2024","unstructured":"Arnold DT, Read L, Waddington O, et al. Antibiotic pharmacokinetics in infected pleural effusions. Thorax. 2024;79:883\u20135.","journal-title":"Thorax"},{"key":"308_CR58","doi-asserted-by":"publisher","first-page":"20190027","DOI":"10.1515\/pp-2019-0027","volume":"5","author":"JM Porcel","year":"2020","unstructured":"Porcel JM, Ferreiro L, Rumi L, et al. Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial. Pleura Peritoneum. 2020;5:20190027.","journal-title":"Pleura Peritoneum"},{"key":"308_CR59","doi-asserted-by":"publisher","first-page":"00635","DOI":"10.1183\/23120541.00635-2022","volume":"9","author":"M Hassan","year":"2023","unstructured":"Hassan M, Gad-Allah M, El-Shaarawy B, El-Shazly AM, Daneshvar C, Sadaka AS. The short versus Long antibiotic course for pleural Infection Management (SLIM) randomised controlled open label trial. ERJ Open Res. 2023;9:00635\u20132022.","journal-title":"ERJ Open Res"},{"key":"308_CR60","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jamcollsurg.2008.01.005","volume":"206","author":"T Ng","year":"2008","unstructured":"Ng T, Ryder BA, Maziak DE, et al. Treatment of postpneumonectomy empyema with debridement followed by continuous antibiotic irrigation. J Am Coll Surg. 2008;206:1178\u201383.","journal-title":"J Am Coll Surg"},{"key":"308_CR61","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.4081\/idr.2014.5413","volume":"6","author":"MA Rana","year":"2014","unstructured":"Rana MA, El Rahman BA, Mady AF, et al. Intra-pleural colistin methanesulfonate therapy for pleural infection caused by carbapenem-resistant Acinetobacter baumannii: a successful case report. Infect Dis Rep. 2014;6:5413.","journal-title":"Infect Dis Rep"},{"key":"308_CR62","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1164\/rccm.202201-0057ED","volume":"205","author":"DT Arnold","year":"2022","unstructured":"Arnold DT, Maskell NA. Corticosteroids for pleural infection: should we STOPPE studying? Am J Respir Crit Care Med. 2022;205:987\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"308_CR63","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1164\/rccm.202107-1600OC","volume":"205","author":"DB Fitzgerald","year":"2022","unstructured":"Fitzgerald DB, Waterer GW, Budgeon C, et al. Steroid Therapy and outcome of parapneumonic pleural effusions (STOPPE): a pilot randomized clinical trial. Am J Respir Crit Care Med. 2022;205:1093\u2013101.","journal-title":"Am J Respir Crit Care Med"},{"key":"308_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13665-017-0162-3","volume":"6","author":"RJ Hallifax","year":"2017","unstructured":"Hallifax RJ, Psallidas I, Rahman NM. Chest drain size: the debate continues. Curr Pulmonol Rep. 2017;6:26\u20139.","journal-title":"Curr Pulmonol Rep"},{"key":"308_CR65","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1378\/chest.09-1044","volume":"137","author":"NM Rahman","year":"2010","unstructured":"Rahman NM, Maskell NA, Davies CW, et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest. 2010;137:536\u201343.","journal-title":"Chest"},{"key":"308_CR66","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa1012740","volume":"365","author":"NM Rahman","year":"2011","unstructured":"Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518\u201326.","journal-title":"N Engl J Med"},{"key":"308_CR67","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1440-1843.2008.01296.x","volume":"13","author":"HE Davies","year":"2008","unstructured":"Davies HE, Merchant S, McGown A. A study of the complications of small bore \u2018Seldinger\u2019 intercostal chest drains. Respirology. 2008;13:603\u20137.","journal-title":"Respirology"},{"key":"308_CR68","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1183\/09031936.00147214","volume":"46","author":"CE Hooper","year":"2015","unstructured":"Hooper CE, Edey AJ, Wallis A, et al. Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection. Eur Respir J. 2015;46:456\u201363.","journal-title":"Eur Respir J"},{"key":"308_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084788","volume":"9","author":"J Letheulle","year":"2014","unstructured":"Letheulle J, Tattevin P, Saunders L, et al. Iterative thoracentesis as first-line treatment of complicated parapneumonic effusion. PLoS ONE. 2014;9: e84788.","journal-title":"PLoS ONE"},{"key":"308_CR70","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12890-022-02126-4","volume":"22","author":"DT Arnold","year":"2022","unstructured":"Arnold DT, Tucker E, Morley A, et al. A feasibility randomised trial comparing therapeutic thoracentesis to chest tube insertion for the management of pleural infection: results from the ACTion trial. BMC Pulm Med. 2022;22:330.","journal-title":"BMC Pulm Med"},{"key":"308_CR71","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1378\/chest.07-1742","volume":"133","author":"HE Davies","year":"2008","unstructured":"Davies HE, Rahman NM, Parker RJ, Davies RJO. Use of indwelling pleural catheters for chronic pleural infection. Chest. 2008;133:546\u20139.","journal-title":"Chest"},{"key":"308_CR72","unstructured":"National Institute for Health and Care Research. Award ID: NIHR159462. Initial management of pleural infection: aspiration versus chest tube (IMPACT) trial. 2025. Available at: https:\/\/fundingawards.nihr.ac.uk\/award\/NIHR159462. Accessed 7 July 2025."},{"key":"308_CR73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/CPM.0000000000000216","volume":"24","author":"S Idell","year":"2017","unstructured":"Idell S, Florova G, Shetty S, et al. Precision-guided, personalized intrapleural fibrinolytic therapy for empyema and complicated parapneumonic pleural effusions: the case for the fibrinolytic potential. Clin Pulm Med. 2017;24:163\u20139.","journal-title":"Clin Pulm Med"},{"key":"308_CR74","first-page":"002312","volume":"10","author":"ES Altmann","year":"2019","unstructured":"Altmann ES, Crossingham I, Wilson S, Davies HR. 2019 Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2019;10:002312.","journal-title":"Cochrane Database Syst Rev"},{"key":"308_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257339","volume":"16","author":"D Luque Paz","year":"2021","unstructured":"Luque Paz D, Bayeh B, Chauvin P, et al. Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: a comparative cohort study. PLoS ONE. 2021;16: e0257339.","journal-title":"PLoS ONE"},{"key":"308_CR76","doi-asserted-by":"publisher","first-page":"00084","DOI":"10.1183\/23120541.00084-2019","volume":"5","author":"B B\u00e9dat","year":"2019","unstructured":"B\u00e9dat B, Plojoux J, Noel J, et al. Comparison of intrapleural use of urokinase and tissue plasminogen activator\/DNAse in pleural infection. ERJ Open Res. 2019;5:00084\u20132019.","journal-title":"ERJ Open Res"},{"key":"308_CR77","unstructured":"British Thoracic Society. BTS response to the national shortage of alteplase in relation to pleural infection management. 2022. Available at: https:\/\/www.brit-thoracic.org.uk\/news\/2022\/bts-response-to-the-national-shortage-of-alteplase-in-relation-to-pleural-infection-management\/. Accessed 12 May 2025."},{"key":"308_CR78","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/resp.14261","volume":"27","author":"N Popowicz","year":"2022","unstructured":"Popowicz N, Ip H, Lau EPM, et al. Alteplase dose assessment for pleural infection therapy (ADAPT) study-2: use of 2.5 mg alteplase as a starting intrapleural dose. Respirology. 2022;27:510\u20136.","journal-title":"Respirology."},{"key":"308_CR79","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000443334","volume":"91","author":"HJ Mehta","year":"2016","unstructured":"Mehta HJ, Biswas A, Penley AM, Cope J, Barnes M, Jantz MA. Management of intrapleural sepsis with once daily use of tissue plasminogen activator and deoxyribonuclease. Respiration. 2016;91:101\u20136.","journal-title":"Respiration"},{"key":"308_CR80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13256-015-0775-5","volume":"9","author":"SV Vun","year":"2015","unstructured":"Vun SV, Lance DG. Life-threatening pleural hemorrhage following intrapleural enzyme therapy and successful treatment with fibrin-thrombin sealant pleurodesis: a case report. J Med Case Rep. 2015;9:287.","journal-title":"J Med Case Rep"},{"key":"308_CR81","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.chest.2022.06.008","volume":"162","author":"J Akulian","year":"2022","unstructured":"Akulian J, Bedawi EO, Abbas H, et al. Bleeding risk with combination intrapleural fibrinolytic and enzyme therapy in pleural infection: an international, multicenter, retrospective cohort study. Chest. 2022;162:1384\u201392.","journal-title":"Chest"},{"key":"308_CR82","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1378\/chest.118.4.1158","volume":"118","author":"GL Colice","year":"2000","unstructured":"Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest. 2000;118:1158\u201371.","journal-title":"Chest"},{"key":"308_CR83","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/ejcts\/ezv272","volume":"48","author":"M Scarci","year":"2015","unstructured":"Scarci M, Abah U, Solli P, et al. EACTS expert consensus statement for surgical management of pleural empyema. Eur J Cardiothorac Surg. 2015;48:642\u201353.","journal-title":"Eur J Cardiothorac Surg"},{"key":"308_CR84","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.athoracsur.2009.09.021","volume":"89","author":"BC Tong","year":"2010","unstructured":"Tong BC, Hanna J, Toloza EM, et al. Outcomes of video-assisted thoracoscopic decortication. Ann Thorac Surg. 2010;89:220\u20135.","journal-title":"Ann Thorac Surg"},{"key":"308_CR85","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.athoracsur.2007.03.019","volume":"84","author":"DTL Chan","year":"2007","unstructured":"Chan DTL, Sihoe ADL, Chan S, et al. Surgical treatment for empyema thoracis: is video-assisted thoracic surgery \u201cbetter\u201d than thoracotomy? Ann Thorac Surg. 2007;84:225\u201331.","journal-title":"Ann Thorac Surg"},{"key":"308_CR86","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jtcvs.2018.10.157","volume":"157","author":"CW Towe","year":"2019","unstructured":"Towe CW, Carr SR, Donahue JM, et al. Morbidity and 30-day mortality after decortication for parapneumonic empyema and pleural effusion among patients in the society of thoracic surgeons\u2019 general thoracic surgery database. J Thorac Cardiovasc Surg. 2019;157:1288\u201397.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"308_CR87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/0218492311435338","volume":"20","author":"MIA Muhammad","year":"2012","unstructured":"Muhammad MIA. Management of complicated parapneumonic effusion and empyema using different treatment modalities. Asian Cardiovasc Thorac Ann. 2012;20:177\u201381.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"308_CR88","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.athoracsur.2013.06.013","volume":"96","author":"A Stefani","year":"2013","unstructured":"Stefani A, Aramini B, Della Casa G, et al. Preoperative predictors of successful surgical treatment in the management of parapneumonic empyema. Ann Thorac Surg. 2013;96:1812\u20139.","journal-title":"Ann Thorac Surg"},{"key":"308_CR89","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.athoracsur.2004.12.031","volume":"79","author":"D Lardinois","year":"2005","unstructured":"Lardinois D, Gock M, Pezzetta E, et al. Delayed referral and gram-negative organisms increase the conversion thoracotomy rate in patients undergoing video-assisted thoracoscopic surgery for empyema. Ann Thorac Surg. 2005;79:1851\u20136.","journal-title":"Ann Thorac Surg"},{"key":"308_CR90","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1164\/rccm.202305-0854OC","volume":"208","author":"EO Bedawi","year":"2023","unstructured":"Bedawi EO, Stavroulias D, Hedley E, et al. Early video-assisted thoracoscopic surgery or intrapleural enzyme therapy in pleural infection: a feasibility randomized controlled trial. The third multicenter intrapleural sepsis trial\u2014MIST-3. Am J Respir Crit Care Med. 2023;208:1305\u201315.","journal-title":"Am J Respir Crit Care Med"},{"key":"308_CR91","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.7799","volume":"6","author":"CL Wilshire","year":"2023","unstructured":"Wilshire CL, Jackson AS, Vallieres E, et al. Effect of intrapleural fibrinolytic therapy vs surgery for complicated pleural infections: a randomized clinical trial. JAMA Netw Open. 2023;6: e237799.","journal-title":"JAMA Netw Open"},{"key":"308_CR92","unstructured":"National Institute for Health and Care Research. Award ID: NIHR161731. The 4th Multicentre Intrapleural Sepsis Trial (MIST4)\u2014a definitive randomised clinical effectiveness study comparing initial video assisted thoracic surgery and intrapleural enzyme therapy in adult patients with pleural infection. 2025 Available at: https:\/\/fundingawards.nihr.ac.uk\/award\/NIHR161731 Accessed 10 June 2025."},{"key":"308_CR93","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054236","volume":"12","author":"TD Christensen","year":"2022","unstructured":"Christensen TD, Bendixen M, Skaarup SH, et al. Intrapleural fibrinolysis and DNase versus video-assisted thoracic surgery (VATS) for the treatment of pleural empyema (FIVERVATS): protocol for a randomised, controlled trial\u2014surgery as first-line treatment. BMJ Open. 2022;12: e054236.","journal-title":"BMJ Open"},{"key":"308_CR94","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12890-021-01492-9","volume":"21","author":"M Mondoni","year":"2021","unstructured":"Mondoni M, Saderi L, Trogu F, et al. Medical thoracoscopy treatment for pleural infections: a systematic review and meta-analysis. BMC Pulm Med. 2021;21:127.","journal-title":"BMC Pulm Med"},{"key":"308_CR95","unstructured":"ISRCTN Registry: ISRCTN98460319. A trial to investigate whether pleuroscopy can be used to treat pleural infection. 2025 Available at: https:\/\/www.isrctn.com\/ISRCTN98460319 Accessed 10 June 2025."},{"key":"308_CR96","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1378\/chest.13-1558","volume":"145","author":"NM Rahman","year":"2014","unstructured":"Rahman NM, Kahan BC, Miller RF, et al. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014;145:848\u201355.","journal-title":"Chest"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-025-00308-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-025-00308-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-025-00308-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:55:31Z","timestamp":1757292931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-025-00308-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1007\/s41030-025-00308-z","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Steven J Smith and Benjamin J Pippard declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}